[ad_1]
IN Britain has become the first country in the world to approve the Pfizer / BioNTech vaccine against COVID-19 and has announced that it will start vaccines early next week, Reuters reported.
Is vaccination against COVID-19 possible in December?
UK Approves Pfizer-BioNTech COVID-19 Vaccine, World’s First https://t.co/adDpXPv49j pic.twitter.com/mEYHYEvUrk
– Reuters (@Reuters) December 2, 2020
The government has accepted the recommendations of the independent regulatory agency for drugs and health products to make this a reality.
The vaccine will be available for use in the UK from next week.
Pfizer commented that the rush issued permit is a historic moment in the fight against COVID-19.
A virologist explained how the Covid-19 vaccine works, if it is dangerous
British Health Minister Matt Hancock announced that the vaccination program in the country will start early next week and that hospitals are ready.
Health workers, the elderly and people with serious illnesses are expected to be the first to be immunized, according to the Ministry of Health and Social Welfare.
When will the first vaccine arrive in Bulgaria?
The UK has ordered 40 million doses of the vaccine, covering about 60% of the country’s population. Delivery will start immediately. Health Minister Matt Hancock said he expects 10 million doses to be delivered by the end of 2020.
Yesterday, German biotech company BioNTech and its US partner Pfizer announced that they had submitted documents to obtain permission from the EU regulator to administer its COVID-19 vaccine.
The vaccine is expected to be approved by the United States and the European Union in late December.
Covid-19: The AstraZeneca “Wrong” Vaccine
Analysis of the results of a large clinical trial showed that the vaccine was 95% effective against the coronavirus and did not cause serious side effects.
The Moderna and Pfizer / BioNTech vaccines are based on a new technology that uses mRNA to deliver genetic material to the body for human cells to make proteins from the virus. This trains the immune system to be ready to attack if it faces the new coronavirus.
England comes out of a four-week quarantine today and returns to a regional focus on the limitations Prime Minister Boris Johnson hopes to remove in the spring thanks to the combined effects of vaccines and massive testing, AFP reported.
This was the second quarantine in England. It aimed to stop the second wave of coronavirus in the country, most affected by the pandemic among European countries (more than 59,000 deaths out of 1.6 million infected).
At least until February, a three-level alarm system will be introduced and local restrictions will be imposed according to the severity of the epidemic.
As part of the relaxation undertaken across England, non-essential shops are able to welcome customers back, a huge relief for retailers before Christmas approaches, a traditionally strong time for their businesses.
You can also open sports halls, resume services and weddings.
Residents of the region can now gather, a maximum of six, and outdoors, only if a maximum alarm level has been declared in their area.
Almost all of England, with a population of around 55 million, has a second or third alert level, except for the Isle of Wight, Cornwall and the Isle of Wight, where the first lowest level has been declared.
The restrictions (which affect in particular the operation of pubs and restaurants, as well as indoor gatherings) are stricter than before the quarantine. This angered many lawmakers, including Prime Minister Johnson’s conservatives.
Yesterday, the president of the European Commission, Ursula von der Leyen, said that the EU had already provided around two billion doses of coronavirus vaccines and that the first citizens of the bloc could be vaccinated before the end of December.
However, earlier in the day, the Financial Times quoted its sources as saying that the European Union was unlikely to start distributing coronavirus vaccines until early next year.
According to people familiar with the candidate vaccine, made by Pfizer Inc. and BioNTech SE, it is expected to receive an opinion from the European Medicines Agency (EMA) on December 29 only.
The European Medicines Agency is evaluating data on COVID-19 vaccines produced by Pfizer / BioNTech, and it is not yet possible to say when it will issue an opinion, a European Commission spokesman said yesterday.
He explained that if the vaccines are evaluated positively, the EC will have to approve the admission of the products to the EU market.
Before the commission can make a decision, EU countries must also approve access to vaccines.
It will take a qualified majority among the EU countries (55% of the countries representing 65% of the European population) for the EC to come out in favor.
The Commission is ready to grant market access a few days after the positive opinion of the Medicines Agency.
The commission will act on the case under an urgent procedure, added its spokesperson. He stressed that the EC is ready to provide EU countries with assistance for the transport and storage of vaccines.
According to him, after the pharmaceutical agency and the EC grant permission, the supply of vaccines will be negotiated directly between countries and manufacturers.
He called for vaccine provision and speculation not to be confused with the market value of pharmaceutical companies following reports of a successful vaccine.
We are waiting for the first vaccines when the vaccination begins
Today it was clear that on Thursday the Bulgarian Ministry of Health will develop a National Vaccination Plan against COVID-19. This was announced in an extraordinary briefing at the Cabinet of Health Minister Kostadin Angelov.
[ad_2]
